Oncimmune

Oncimmune is a biotechnology company specializing in antibody and autoantibody biomarker discovery for precision medicine. Its proprietary ImmunoINSIGHTS platform screens against 9,000+ human antigens using Luminex xMAP bead-based multiplexed immunoassay technology, minimal sample volumes, high-throughput automated robotic workflows, and proprietary machine-learning algorithms to identify immune-system signatures across immuno-oncology, autoimmune disease, and infectious disease. Products include the ImmunoINSIGHTS 2K targeted panels, custom biomarker discovery services, and bioinformatics/data-science multiomics integration. Oncimmune was acquired by Alden Scientific in July 2025. The company operates as a research and discovery services provider and does not publish a public developer or API platform.

Oncimmune is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Precision Medicine, Biomarker Discovery, and Immuno-Oncology.

Oncimmune’s developer surface includes support and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPrecision MedicineBiomarker DiscoveryImmuno-OncologyAutoantibodyDiagnosticsLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.9 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/oncimmune: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: oncimmune
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/oncimmune.png
name: Oncimmune
description: Oncimmune is a biotechnology company specializing in antibody and autoantibody biomarker discovery for precision
  medicine. Its proprietary ImmunoINSIGHTS platform screens against 9,000+ human antigens using Luminex xMAP bead-based multiplexed
  immunoassay technology, minimal sample volumes, high-throughput automated robotic workflows, and proprietary machine-learning
  algorithms to identify immune-system signatures across immuno-oncology, autoimmune disease, and infectious disease. Products
  include the ImmunoINSIGHTS 2K targeted panels, custom biomarker discovery services, and bioinformatics/data-science multiomics
  integration. Oncimmune was acquired by Alden Scientific in July 2025. The company operates as a research and discovery services
  provider and does not publish a public developer or API platform.
url: https://raw.githubusercontent.com/api-evangelist/oncimmune/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- balderton-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biotechnology
- Precision Medicine
- Biomarker Discovery
- Immuno-Oncology
- Autoantibody
- Diagnostics
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.oncimmune.com/
- type: Support
  url: https://www.oncimmune.com/contact/
- type: PrivacyPolicy
  url: https://www.oncimmune.com/privacy-policy/
- type: TermsOfService
  url: https://www.oncimmune.com/terms-of-use/
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1